Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

FEBS Letters

Volumn 423, Issue 1, 1998, Pages 57-60

  MacKness, Bharti ^a   MacKness, Michael I ^a   Arrol, Sharon ^a   Turkie, Wajdi ^a   Durrington, Paul N ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Atherosclerosis; High density lipoprotein; Lipid peroxide; Low density lipoprotein; Paraoxonase

Indexed keywords

ALLOENZYME; ARYLESTERASE; COPPER ION; HIGH DENSITY LIPOPROTEIN; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENETIC POLYMORPHISM; HUMAN; LIPID OXIDATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SERUM;

ADULT; ARYLDIALKYLPHOSPHATASE; ESTERASES; GENOTYPE; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0032512704     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00064-7     Document Type: Article

References (27)

1. Serrato M., Marian A.J. J. Clin. Invest. 96:1995;3005-3008.
2. Mackness M.I., Durrington P.N. Atherosclerosis. 115:1995;243-253.
3. Mackness M.I., Abbott C.A., Arrol S., Durrington P.N. Biochem. J. 294:1993;829-835.
4. Mackness M.I., Arrol S., Durrington P.N. FEBS Lett. 286:1991;152-154.
5. Mackness M.I., Arrol S., Abbott C.A., Durrington P.N. Atherosclerosis. 104:1993;129-135.
6. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Fault K.F., Fogelman A.M., Navab M. J. Clin. Invest. 96:1995;2882-2891.
7. Navab M.S., Hama-Levy S., Van Leuten B.J., Fonarow G.C., Cardinez C.J., Castellani L.W., Bennan M.-L., Lusis A.J., Fogelman A.M. J. Clin. Invest. 99:1997;2005-2019.
8. McElveen J., Mackness M.I., Colley C.M., Peard T., Warner S., Walker C.H. Clin. Chem. 32:1986;671-673.
9. Abbott C.A., Mackness M.I., Kumar S., Boulton A.J.M., Durrington P.N. Arterioscler. Thromb. Vasc. Biol. 15:1995;1812-1818.
10. Adkins S., Gan K.N., Mody M., La Du B.N. Am. J. Hum. Genet. 52:1993;598-608.
11. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., Furlong C.E. Nature Genet. 3:1993;73-76.
12. Davies H.G., Richter R.J., Keifer M., Broomfield C.A., Sowalla J., Furlong C.E. Nature Genet. 14:1996;334-336.
13. Blatter-Garin M.-C., James R.W., Dussoix P., Blanché H., Passa P., Froguel P., Ruiz J. J. Clin. Invest. 99:1997;62-66.
14. Mackness B., Mackness M.I., Arrol S., Turkie W., Durrington P.N. Br. J. Pharmacol. 112:1997;265-268.
15. Ruiz J., Blanché H., James R.W., Blatter-Garin M.-C., Vaise C., Charpeutier G., Cohen N., Morabia A., Possa P., Froguel P. Lancet. 346:1995;869-872.
16. Serrato M., Marian A.J. J. Clin. Invest. 96:1995;3005-3008.
17. Odawara M., Tachi Y., Yamashita K. J. Clin. Endocrinol. Metab. 82:1997;2257-2260.
18. Sanghera D.K., Saha N., Aston C.E., Kamboh M.I. Arterioscl. Thromb. Vasc. Biol. 17:1997;1067-1073.
19. Antikainen M., Murtomäki S., Syvänne M., Pahlman R., Tahvanainen E., Jauhiainen M., Frick M.H., Ehnholm C. J. Clin. Invest. 98:1996;883-885.
20. Herrmann S.M., Blanc H., Poirier O., Arveiter D., Luc G., Evans A., Marques-Vidal P., Bard J.M., Cambien F. Atherosclerosis. 126:1996;299.
21. Mackness, M.I. and Durrington, P.N. (1992) in: Lipoprotein Analysis: a Practical Approach (Converse, C.A. and Skinner, E.R., Eds.) pp. 1-42, IRL Press, Oxford, UK.
22. Mackness M.I., Arrol S., Mackness B., Durrington P.N. Lancet. 349:1997;851-852.
23. Miller G.J., Miller N.E. Lancet. i:1975;16-19.
24. Mackness B., Hunt R., Durrington P.N., Mackness M.I. Arterioscler. Thromb. Vasc. Biol. 17:1997;1233-1238.
25. Mackness M.I., Mackness B., Arrol S., Wood G., Bhatnagar D., Durrington P.N. FEBS Lett. 416:1997;377-380.
26. Watson A.D., Navab M., Hama S.Y., Sevanian A., Prescott S.M., Stafforini D.M., McIntyre T.M., La Du B.N., Fogelman A.M., Berliner J.A. J. Clin. Invest. 95:1995;774-782.
27. Klimov A.N., Nikiforova A.A., Pleskov V.M., Kuz'min A.A., Kalashnikova N.N., Antipova T.O. Biokhimiya. 54:1989;118-123.